PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
01-Jun-2023 Global Analgesics Market Report 2023: Sector is Expected to Reach $67.55 Billion by 2028 at a CAGR of 4.6% - ResearchAndMarkets.com Businesswire
01-Jun-2023 United States Vaccine Packaging Market 2023 - 2028: Substantial Involvement of Government in Vaccination Programs Drives Growth - ResearchAndMarkets.com Businesswire
01-Jun-2023 Median Technologies to participate in the 2023 ASCO Annual Meeting, June 2-6, 2023, McCormick Place, Chicago, IL, USA Businesswire
01-Jun-2023 ライナスバイオ、市場の減速を乗り越え、バリュエーションの回復を背景にシリーズA2で800万ドル追加調達 Businesswire
01-Jun-2023 Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology Businesswire
01-Jun-2023 Paige Introduces New AI-Based Biomarker Screening Advancement to Drastically Reduce Diagnostic Turnaround Times and Inform Precision Treatment Decisions Businesswire
01-Jun-2023 Phase 3 Studies of Pfizer’s Novel Antibiotic Combination Offer New Treatment Hope for Patients with Multidrug-Resistant Infections and Limited Treatment Options Businesswire
01-Jun-2023 Ondine Biomedical Appoints Senior Pharma Executive Dr. Simon Sinclair as Chief Medical Officer Businesswire
01-Jun-2023 Pro-ficiency Launches Pf Library to Expand Study Training Service Suite Newswire
01-Jun-2023 PTP Announces Significant Investment by 424 Capital Businesswire
01-Jun-2023 Masimo Board of Directors Sets the Record Straight on False and Misleading Claims Businesswire
01-Jun-2023 Seven and Eight Biopharmaceuticals Announces Exclusive Clinical License Agreement with Eikon Therapeutics to Develop and Commercialize TLR7/8 dual agonists Businesswire
01-Jun-2023 Revvity’s EUROIMMUN Spearheads Cutting-Edge Diagnostic Analysis with New Automated IIFT System Businesswire
01-Jun-2023 Edge Group Global LLC Acquires Italian Soccer Team Casale Businesswire
01-Jun-2023 Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for ARCT-810, mRNA Therapeutic Candidate for Ornithine Transcarbamylase Deficiency Businesswire
01-Jun-2023 Vistagen Presents Fasedienol (PH94B) Safety and Exploratory Efficacy Data from Phase 3 Open-Label Social Anxiety Disorder Study at American Society for Clinical Psychopharmacology Annual Meeting Businesswire
01-Jun-2023 Eikon Therapeutics Builds Leading Clinical Development Organization with Appointment of Senior Team with Extensive Industry Expertise Businesswire
01-Jun-2023 Biomarker Analysis Publication Highlights Key Signals of Disability Worsening Associated With Neuromyelitis Optica Spectrum Disorder (NMOSD) Attacks, Illustrates Efficacy of UPLIZNA® (inebilizumab-cdon) Businesswire
01-Jun-2023 Clarametyx Announces Positive Early Phase 1 Safety Findings on CMTX-101, Immune-Enabling Antibody Therapy Businesswire
01-Jun-2023 Massive Bio Launches Revolutionary ChatGPT-Powered Chatbot Platform at ASCO 2023 to Simplify and Expand Access to Oncology Clinical Trials Businesswire